Composition For Enhancing Iron Absorption

Itc Limited
Awaiting Nba Approval App No 201941011121 Biotechnology

Patent information

IP India · live record
Application number
201941011121
Filing date
22 March 2019
Status
Awaiting Nba Approval
Publication number
39/2020
Publication type
INA
Invention field
Biotechnology

Abstract

The present disclosure discloses a composition comprising a) Zingiber officinale extract; and b) at least one vitamin B, wherein the Zingiber officinale extract to the at least one vitamin B weight ratio is in a range of 1:0.00006 to 1:0.001. The composition of the present disclosure increases the absorption of iron from the diet. Also, provided is a process for preparing the composition

Applicants

1
India
ITC LIMITED ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1st Main, Peenya Industrial Area, Phase-1, Bangalore 560 058, India.

Inventors

4
India
KOPPALA, ParameswariITC Limited, ITC Life Sciences & Technology Centre, No.3, 1st Main Road, Peenya Industrial Area, Phase-I, Bengaluru, India.
India
KAUSHAL, DeeptiITC Limited, ITC Life Sciences & Technology Centre, No.3, 1st Main Road, Peenya Industrial Area, Phase-I, Bengaluru, India
India
KALSI, GurpreetITC Limited, ITC Life Sciences & Technology Centre, No.3, 1st Main Road, Peenya Industrial Area, Phase-I, Bengaluru, India
India
CHANDRASEKHARAN, Lakshmanan ChitturITC Limited, ITC Life Sciences & Technology Centre, No.3, 1st Main Road, Peenya Industrial Area, Phase-I, Bengaluru, India

Claims

11
1 A composition comprising: a) Zingiber officinale extract; and b) at least one vitamin B, wherein the Zingiber officinale extract to the at least one vitamin B weight ratio is in a range of 1:0.00006 to 1:0.001.
2 The composition as claimed in claim 1, wherein the Zingiber officinale extract to the at least one vitamin B weight ratio is in a range of 1:0.00007 to 1:0.0008.
3 The composition as claimed in claim 1, wherein the Zingiber officinale extract comprises Zingiber officinale ol in a weight percentage in a range of 6-8% with respect to the Zingiber officinale extract.
4 The composition as claimed in claim 1, wherein the at least one vitamin B is selected from a group consisting of vitamin B9, vitamin B6, vitamin B12, and combinations thereof.
5 The composition as claimed in claim 4, wherein the at least one vitamin B is vitamin B9.
6 The composition as claimed in claim 1, wherein the Zingiber officinale extract has a weight percentage in a range of 0.03 to 0.3% with respect to the composition.
7 The composition as claimed in claim 1, wherein the at least one vitamin B has a weight percentage in a range of 0.000006 to 0.0003% with respect to the composition.
8 The composition as claimed in claim 1, wherein the Zingiber officinale extract has a concentration in a range of 12µg/ml to 70 µg/ml with respect to the composition, and the at least one vitamin B has a concentration in a range of 3.5ng/ml to 8ng/ml with respect to the composition.
9 The composition as claimed in claim 1, wherein the composition further comprises at least one excipient selected from a group consisting of fibre, flour, fat, colour, protein supplement, and combinations thereof.
10 A process for preparing the composition as claimed in claim 1, said process comprising: a) obtaining the Zingiber officinale extract; b) obtaining the at least one vitamin B; and c) contacting the Zingiber officinale extract and the at least one vitamin B, to obtain the composition.
11 A process for preparing the composition as claimed in claim 9, said process comprising: a) obtaining the Zingiber officinale extract; b) obtaining the at least one vitamin B; c) obtaining the at least one excipient; and d) contacting the Zingiber officinale extract, the at least one vitamin B, and the at least one excipient, to obtain the composition.

Specification

Show full textCollapse

I/We Claim: 1. A composition comprising: a) Zingiber officinale extract; and b) at least one vitamin B, wherein the Zingiber officinale extract to the at least one vitamin B weight ratio is in a range of 1:0.00006 to 1:0.001. 2. The composition as claimed in claim 1, wherein the Zingiber officinale extract to the at least one vitamin B weight ratio is in a range of 1:0.00007 to 1:0.0008. 3. The composition as claimed in claim 1, wherein the Zingiber officinale extract comprises Zingiber officinale ol in a weight percentage in a range of 6-8% with respect to the Zingiber officinale extract. 4. The composition as claimed in claim 1, wherein the at least one vitamin B is selected from a group consisting of vitamin B9, vitamin B6, vitamin B12, and combinations thereof. 5. The composition as claimed in claim 4, wherein the at least one vitamin B is vitamin B9. 6. The composition as claimed in claim 1, wherein the Zingiber officinale extract has a weight percentage in a range of 0.03 to 0.3% with respect to the composition. 7. The composition as claimed in claim 1, wherein the at least one vitamin B has a weight percentage in a range of 0.000006 to 0.0003% with respect to the composition. 8. The composition as claimed in claim 1, wherein the Zingiber officinale extract has a concentration in a range of 12µg/ml to 70 µg/ml with respect to the composition, and the at least one vitamin B has a concentration in a range of 3.5ng/ml to 8ng/ml with respect to the composition. 9. The composition as claimed in claim 1, wherein the composition further comprises at least one excipient selected from a group consisting of fibre, flour, fat, colour, protein supplement, and combinations thereof.

10. A process for preparing the composition as claimed in claim 1, said process comprising: a) obtaining the Zingiber officinale extract; b) obtaining the at least one vitamin B; and c) contacting the Zingiber officinale extract and the at least one vitamin B, to obtain the composition. 11. A process for preparing the composition as claimed in claim 9, said process comprising: a) obtaining the Zingiber officinale extract; b) obtaining the at least one vitamin B; c) obtaining the at least one excipient; and d) contacting the Zingiber officinale extract, the at least one vitamin B, and the at least one excipient, to obtain the composition.

Documents

Sign in to open
Application documents
1 201941011121-STATEMENT OF UNDERTAKING (FORM 3) [22-03-2019(online)].pdf 22 Mar 2019
2 201941011121-REQUEST FOR EXAMINATION (FORM-18) [22-03-2019(online)].pdf 22 Mar 2019
3 201941011121-FORM 18 [22-03-2019(online)].pdf 22 Mar 2019
4 201941011121-FORM 1 [22-03-2019(online)].pdf 22 Mar 2019
5 201941011121-DRAWINGS [22-03-2019(online)].pdf 22 Mar 2019
6 201941011121-DECLARATION OF INVENTORSHIP (FORM 5) [22-03-2019(online)].pdf 22 Mar 2019
7 201941011121-COMPLETE SPECIFICATION [22-03-2019(online)].pdf 22 Mar 2019
8 201941011121-Proof of Right (MANDATORY) [22-04-2019(online)].pdf 22 Apr 2019
9 201941011121-FORM-26 [22-04-2019(online)].pdf 22 Apr 2019
10 Correspondence by Agent_Form 26_24-04-2019.pdf 24 Apr 2019
11 Correspondence by Agent_Form 1-Proof of Right_24-04-2019..pdf 24 Apr 2019
12 201941011121-Response to office action [15-07-2021(online)].pdf 15 Jul 2021
13 201941011121-FER.pdf 17 Oct 2021
14 Important Correspondence from NBA 10-11-2021.pdf 10 Nov 2021
15 201941011121-Response to office action [03-08-2022(online)].pdf 03 Aug 2022
16 201941011121-US(14)-HearingNotice-(HearingDate-05-10-2023).pdf 08 Sep 2023
17 201941011121-Correspondence to notify the Controller [03-10-2023(online)].pdf 03 Oct 2023
18 201941011121-FORM-26 [04-10-2023(online)].pdf 04 Oct 2023
19 201941011121-Written submissions and relevant documents [19-10-2023(online)].pdf 19 Oct 2023
20 201941011121-NBA INTIMATION TO APPLICANT COMPLY WITH REQUIREMENT-07-12-2023.pdf 07 Dec 2023
Search strategy
12021-01-1517-13-36E_15-01-2021.pdf